Tumor lymphangiogenesis as a potential therapeutic target

Journal of Oncology

Volumn , Issue , 2012, Pages

  Duong, Tam ^a   Koopman, Peter ^a   Francois, Mathias ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5,6,7,13 TETRAHYDRO 12 (3 HYDROXYPROPYL) 9 ISOPROPOXYMETHYLINDENO[2,1 A]PYRROLO[3,4 C]CARBAZOL 5(12H) ONE DIMETHYLGLYCINE ESTER; ANGIOPOIETIN 2; BONE MORPHOGENETIC PROTEIN 4; CD11B ANTIGEN; CD34 ANTIGEN; CELECOXIB; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; DOXORUBICIN; ENDOTHELIN 1; EPHRIN B2; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR AB; SCATTER FACTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; SOMATOMEDIN B; SOMATOMEDIN C; SORAFENIB; SUNITINIB; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SOX18; TRANSFORMING GROWTH FACTOR BETA2; UNINDEXED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VATALANIB;

ANGIOGENESIS; BONE MARROW CELL; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CARCINOGENESIS; CARCINOMATOSIS; CELL DIFFERENTIATION; CELL EXPANSION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; DISTANT METASTASIS; EMBRYO; ENDOTHELIUM CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG CANCER; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; LYMPHOID TISSUE; MELANOMA; METASTASIS; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SENTINEL LYMPH NODE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TUMOR DIFFERENTIATION; TUMOR MICROENVIRONMENT;

EID: 84858307271     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/204946     Document Type: Review

References (231)

1. Paget S., The distribution of secondary growths in cancer of the breast The Lancet 1889 133 3421 571 573
2. Ewing J., Neoplastic Diseases 1928 16 6th Philadelphia, Pa, USA W. B. Saunders
3. Alitalo K., Tammela T., Petrova T. V., Lymphangiogenesis in development and human disease Nature 2005 438 7070 946 953 (Pubitemid 43093960)
4. Shayan R., Achen M. G., Stacker S. A., Lymphatic vessels in cancer metastasis: bridging the gaps Carcinogenesis 2006 27 9 1729 1738 (Pubitemid 44307827)
5. Cao Y., Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis Nature Reviews Cancer 2005 5 9 735 743 (Pubitemid 41486366)
6. Cavanagh L. L., Von Andrian U. H., Travellers in many guises: the origins and destinations of dendritic cells Immunology and Cell Biology 2002 80 5 448 462
7. Sabin F., On the origin of the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig American Journal of Anatomy 1902 1 367 391
8. Van Der Putte S. C. J., The early development of the lymphatic system in mouse embryos Acta Morphologica Neerlando-Scandinavica 1975 13 4 245 286
9. Irrthum A., Devriendt K., Chitayat D., Matthijs G., Glade C., Steijlen P. M., Fryns J. P., Van Steensel M. A. M., Vikkula M., Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia American Journal of Human Genetics 2003 72 6 1470 1478 (Pubitemid 36628386)
10. Franois M., Caprini A., Hosking B., Orsenigo F., Wilhelm D., Browne C., Paavonen K., Karnezis T., Shayan R., Downes M., Davidson T., Tutt D., Cheah K. S. E., Stacker S. A., Muscat G. E. O., Achen M. G., Dejana E., Koopman P., Sox18 induces development of the lymphatic vasculature in mice Nature 2008 456 7222 643 647
11. Lin F. J., Chen X., Qin J., Hong Y. K., Tsai M. J., Tsai S. Y., Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development Journal of Clinical Investigation 2010 120 5 1694 1707
12. Wigle J. T., Oliver G., Prox1 function is required for the development of the murine lymphatic system Cell 1999 98 6 769 778 (Pubitemid 29446894)
13. Johnson N. C., Dillard M. E., Baluk P., M D. M., Harvey N. L., Frase S. L., Oliver G., Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity Genes and Development 2008 22 23 3282 3291
14. Chen Y., Jiang L., She F., Tang N., Wang X., Li X., Han S., Zhu J., Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism Molecular and Cellular Biochemistry 2010 345 1-2 77 89
15. Kulkarni R. M., Greenberg J. M., Akeson A. L., NFATc1 regulates lymphatic endothelial development Mechanisms of Development 2009 126 5-6 350 365
16. Norrmén C., Ivanov K. I., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., Puolakkainen P., Horsley V., Hu J., Augustin H. G., Yl-Herttuala S., Alitalo K., Petrova T. V., FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1 Journal of Cell Biology 2009 185 3 439 457
17. Petrova T. V., Karpanen T., Norrmén C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Yl-Herttuala S., Miura N., Alitalo K., Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis Nature Medicine 2004 10 9 974 981 (Pubitemid 39273739)
18. Karkkainen M. J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T. V., Jeltsch M., Jackson D. G., Talikka M., Rauvala H., Betsholtz C., Alitalo K., Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins Nature Immunology 2004 5 1 74 80 (Pubitemid 38081471)
19. Kchler A. M., Gjini E., Peterson-Maduro J., Cancilla B., Wolburg H., Schulte-Merker S., Development of the zebrafish lymphatic system requires vegfc signaling Current Biology 2006 16 12 1244 1248 (Pubitemid 43867297)
20. Yaniv K., Isogai S., Castranova D., Dye L., Hitomi J., Weinstein B. M., Live imaging of lymphatic development in the zebrafish Nature Medicine 2006 12 6 711 716 (Pubitemid 43865243)
21. Haiko P., Makinen T., Keskitalo S., Taipale J., Karkkainen M. J., Baldwin M. E., Stacker S. A., Achen M. G., Alitalo K., Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos Molecular and Cellular Biology 2008 28 15 4843 4850
22. Baldwin M. E., Halford M. M., Roufail S., Williams R. A., Hibbs M. L., Grail D., Kubo H., Stacker S. A., Achen M. G., Vascular endothelial growth factor D is dispensable for development of the lymphatic system Molecular and Cellular Biology 2005 25 6 2441 2449 (Pubitemid 40354637)
23. Gale N. W., Thurston G., Hackett S. F., Renard R., Wang Q., McClain J., Martin C., Witte C., Witte M. H., Jackson D., Suri C., Campochiaro P. A., Wiegand S. J., Yancopoulos G. D., Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1 Developmental Cell 2002 3 3 411 423
24. Fritz-Six K. L., Dunworth W. P., Li M., Caron K. M., Adrenomedullin signaling is necessary for murine lymphatic vascular development Journal of Clinical Investigation 2008 118 1 40 50
25. Dumont D. J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., Breitman M., Alitalo K., Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 Science 1998 282 5390 946 949 (Pubitemid 28507528)
26. Huang X. Z., Wu J. F., Ferrando R., Lee J. H., Wang Y. L., Farese R. V., Sheppard D., Fatal bilateral chylothorax in mice lacking the integrin 9 1 Molecular and Cellular Biology 2000 20 14 5208 5215 (Pubitemid 30431573)
27. Bazigou E., Xie S., Chen C., Weston A., Miura N., Sorokin L., Adams R., Muro A. F., Sheppard D., Makinen T., Integrin- 9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis Developmental Cell 2009 17 2 175 186
28. Schacht V., Ramirez M. I., Hong Y. K., Hirakawa S., Feng D., Harvey N., Williams M., Dvorak A. M., Dvorak H. F., Oliver G., Detmar M., T1 /podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema EMBO Journal 2003 22 14 3546 3556 (Pubitemid 36898332)
29. Yuan L., Moyon D., Pardanaud L., Bréant C., Karkkainen M. J., Alitalo K., Eichmann A., Abnormal lymphatic vessel development in neuropilin 2 mutant mice Development 2002 129 20 4797 4806 (Pubitemid 35282411)
30. Mkinen T., Adams R. H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., Klein R., Wilkinson G. A., PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature Genes and Development 2005 19 3 397 410 (Pubitemid 40189302)
31. Saharinen P., Helotera H., Miettinen J., Norrmen C., D'Amico G., Jeltsch M., Langenberg T., Vandevelde W., Ny A., Dewerchin M., Carmeliet P., Alitalo K., Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development Genes and Development 2010 24 9 875 880
32. Norrmén C., Vandevelde W., Ny A., Saharinen P., Gentile M., Haraldsen G., Puolakkainen P., Lukanidin E., Dewerchin M., Alitalo K., Petrova T. V., Liprin 1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity Blood 2010 115 4 906 909
33. Hermans K., Claes F., Vandevelde W., Zheng W., Geudens I., Orsenigo F., De Smet F., Gjini E., Anthonis K., Ren B., Kerjaschki D., Autiero M., Ny A., Simons M., Dewerchin M., Schulte-Merker S., Dejana E., Alitalo K., Carmeliet P., Role of synectin in lymphatic development in zebrafish and frogs Blood 2010 116 17 3356 3366
34. Niessen K., Zhang G., Ridgway J. B., Chen H., Yan M., ALK1 signaling regulates early postnatal lymphatic vessel development Blood 2010 115 8 1654 1661
35. Abtahian F., Guerriero A., Sebzda E., Lu M. M., Zhou R., Mocsai A., Myers E. E., Huang B., Jackson D. G., Ferrari V. A., Tybulewicz V., Lowell C. A., Lepore J. J., Koretzky G. A., Kahn M. L., Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk Science 2003 299 5604 247 251 (Pubitemid 36125210)
36. Alders M., Hogan B. M., Gjini E., Salehi F., Al-Gazali L., Hennekam E. A., Holmberg E. E., Mannens M. M. A. M., Mulder M. F., Offerhaus G. J. A., Prescott T. E., Schroor E. J., Verheij J. B. G. M., Witte M., Zwijnenburg P. J., Vikkula M., Schulte-Merker S., Hennekam R. C., Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans Nature Genetics 2009 41 12 1272 1274
37. Hogan B. M., Bos F. L., Bussmann J., Witte M., Chi N. C., Duckers H. J., Schulte-Merker S., Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting Nature Genetics 2009 41 4 396 398
38. Hirashima M., Sano K., Morisada T., Murakami K., Rossant J., Suda T., Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos Developmental Biology 2008 316 1 149 159
39. Danussi C., Spessotto P., Petrucco A., Wassermann B., Sabatelli P., Montesi M., Doliana R., Bressan G. M., Colombatti A., Emilin1 deficiency causes structural and functional defects of lymphatic vasculature Molecular and Cellular Biology 2008 28 12 4026 4039 (Pubitemid 351812988)
40. Pedrioli D. M. L., Karpanen T., Dabouras V., Jurisic G., Van De Hoek G., Shin J. W., Marino D., Klin R. E., Leidel S., Cinelli P., Schulte-Merker S., Brndli A. W., Detmar M., miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo Molecular and Cellular Biology 2010 30 14 3620 3634
41. D'Amico G., Jones D. T., Nye E., Sapienza K., Ramjuan A. R., Reynolds L. E., Robinson S. D., Kostourou V., Martinez D., Aubyn D., Grose R., Thomas G. J., Spencer-Dene B., Zicha D., Davies D., Tybulewicz V., Hodivala-Dilke K. M., Regulation of lymphatic-blood vessel separation by endothelial Rac1 Development 2009 136 23 4043 4053
42. Taniguchi K., Kohno R. I., Ayada T., Kato R., Ichiyama K., Morisada T., Oike Y., Yonemitsu Y., Maehara Y., Yoshimura A., Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling Molecular and Cellular Biology 2007 27 12 4541 4550 (Pubitemid 46906575)
43. Oliver G., Lymphatic vasculature development Nature Reviews Immunology 2004 4 1 35 45 (Pubitemid 38084130)
44. Srinivasan R. S., Geng X., Yang Y., Wang Y., Mukatira S., Studer M., Porto M. P. R., Lagutin O., Oliver G., The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells Genes and Development 2010 24 7 696 707
45. Folkman J., Kaipainen A., Genes tell lymphatics to sprout or not Nature Immunology 2004 5 1 11 12 (Pubitemid 38081460)
46. Kukk E., Lymboussakl A., Taira S., Kaipainen A., Jeltsch M., Joukov V., Alitalo K., VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development Development 1996 122 12 3829 3837 (Pubitemid 27033879)
47. Kaipainen A., Korhonen J., Mustonen T., Van Hinsbergh V. W. M., Fang-G. H., Dumont D., Breitman M., Alitalo K., Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development Proceedings of the National Academy of Sciences of the United States of America 1995 92 8 3566 3570
48. Tammela T., Enholm B., Alitalo K., Paavonen K., The biology of vascular endothelial growth factors Cardiovascular Research 2005 65 3 550 563 (Pubitemid 40138976)
49. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R. K., Alitalo K., Hyperplasia of lymphatic vessels in VEGF-C transgenic mice Science 1997 276 5317 1423 1425 (Pubitemid 27235412)
50. Krpnen T., Heckman C. A., Keskitalo S., Jeltsch M., Ollila H., Neufeld G., Tamagnone L., Alitalo K., Functional interaction of VEGF-C and VEGF-D with neuropilin receptors FASEB Journal 2006 20 9 1462 1472 (Pubitemid 44943854)
51. Tammela T., Alitalo K., Lymphangiogenesis: molecular mechanisms and future promise Cell 2010 140 4 460 476
52. Karpanen T., Alitalo K., Molecular biology and pathology of lymphangiogenesis Annual Review of Pathology 2008 3 367 397 (Pubitemid 351488286)
53. Kim K. E., Cho C. H., Kim H. Z., Baluk P., M D. M., Koh G. Y., In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 3 564 570
54. Morisada T., Oike Y., Yamada Y., Urano T., Akao M., Kubota Y., Maekawa H., Kimura Y., Ohmura M., Miyamoto T., Nozawa S., Koh G. Y., Alitalo K., Suda T., Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation Blood 2005 105 12 4649 4656 (Pubitemid 40807284)
55. Tammela T., Saaristo A., Lohela M., Morisada T., Tornberg J., Norrmén C., Oike Y., Pajusola K., Thurston G., Suda T., Yla-Herttuala S., Alitalo K., Angiopoietin-1 promotes lymphatic sprouting and hyperplasia Blood 2005 105 12 4642 4648 (Pubitemid 40807283)
56. Adams R. H., Eichmann A., Axon guidance molecules in vascular patterning Cold Spring Harbor Perspectives in Biology 2010 2 5 a001875
57. Wang Y., Nakayama M., Pitulescu M. E., Schmidt T. S., Bochenek M. L., Sakakibara A., Adams S., Davy A., Deutsch U., Lthi U., Barberis A., Benjamin L. E., Mkinen T., Nobes C. D., Adams R. H., Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis Nature 2010 465 7297 483 486
58. Fidler I. J., The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nature Reviews Cancer 2003 3 6 453 458 (Pubitemid 37328849)
59. Fidler I. J., Cancer metastasis British Medical Bulletin 1991 47 1 157 177
60. Ungefroren H., Sebens S., Seidl D., Lehnert H., Hass R., Interaction of tumor cells with the microenvironment Cell Communication and Signaling 2011 9 1 18
61. Nowicki A., Szenajch J., Ostrowska G., Wojtowicz A., Wojtowicz K., Kruszewski A. A., Maruszynski M., Aukerman S. L., Wiktor-Jedrzejczak W., Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma International Journal of Cancer 1996 65 1 112 119 (Pubitemid 26030942)
62. Lin E. Y., Nguyen A. V., Russell R. G., Pollard J. W., Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy Journal of Experimental Medicine 2001 193 6 727 740
63. Mantovani A., Allavena P., Sozzani S., Vecchi A., Locati M., Sica A., Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors Seminars in Cancer Biology 2004 14 3 155 160 (Pubitemid 38586740)
64. Barleon B., Sozzani S., Zhou D., Weich H. A., Mantovani A., Marmé D., Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 1996 87 8 3336 3343 (Pubitemid 26115364)
65. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends in Immunology 2002 23 11 549 555 (Pubitemid 35223554)
66. Schoppmann S. F., Birner P., Stckl J., Kalt R., Ullrich R., Caucig C., Kriehuber E., Nagy K., Alitalo K., Kerjaschki D., Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis American Journal of Pathology 2002 161 3 947 956 (Pubitemid 34988382)
67. Chu C. Y., Chang C. C., Prakash E., Kuo M. L., Connective tissue growth factor (CTGF) and cancer progression Journal of Biomedical Science 2008 15 6 675 685
68. Wahab N. A., Weston B. S., Mason R. M., Modulation of the TGF /Smad signaling pathway in mesangial cells by CTGF/CCN2 Experimental Cell Research 2005 307 2 305 314 (Pubitemid 40803489)
69. Kalluri R., Zeisberg M., Fibroblasts in cancer Nature Reviews Cancer 2006 6 5 392 401
70. Hinz B., Phan S. H., Thannickal V. J., Galli A., Bochaton-Piallat M. L., Gabbiani G., The myofibroblast: one function, multiple origins American Journal of Pathology 2007 170 6 1807 1816 (Pubitemid 47339255)
71. Lochter A., Galosy S., Muschler J., Freedman N., Werb Z., Bissell M. J., Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells Journal of Cell Biology 1997 139 7 1861 1872 (Pubitemid 28079248)
72. Polyak K., Weinberg R. A., Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nature Reviews Cancer 2009 9 4 265 273
73. Goumans M. J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., Karlsson S., Ten Dijke P., Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF /ALK5 signaling Molecular Cell 2003 12 4 817 828 (Pubitemid 37352776)
74. Atkins C. D., McCready D. R., Re: influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates Journal of the National Cancer Institute 2004 96 21 1639 1640 (Pubitemid 39534889)
75. Leong S. P. L., Cady B., Jablons D. M., Garcia-Aguilar J., Reintgen D., Jakub J., Pendas S., Duhaime L., Cassell R., Gardner M., Giuliano R., Archie V., Calvin D., Mensha L., Shivers S., Cox C., Werner J. A., Kitagawa Y., Kitajima M., Clinical patterns of metastasis Cancer and Metastasis Reviews 2006 25 2 221 232 (Pubitemid 43890716)
76. Jsukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K., A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases EMBO Journal 1996 15 7 1751 (Pubitemid 26112397)
77. Skobe M., Hawighorst T., Jackson D. G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., Detmar M., Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nature Medicine 2001 7 2 192 198 (Pubitemid 32148486)
78. Karpanen T., Egeblad M., Karkkainen M. J., Kubo H., Yl-Herttuala S., Jttel M., Alitalo K., Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth Cancer Research 2001 61 5 1786 1790 (Pubitemid 32691984)
79. Mattila M. M. T., Ruohola J. K., Karpanen T., Jackson D. G., Alitalo K., Hrknen P. L., VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors International Journal of Cancer 2002 98 6 946 951 (Pubitemid 34286696)
80. Mandriota S. J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D. G., Orci L., Alitalo K., Christofori G., Pepper M. S., Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis EMBO Journal 2001 20 4 672 682 (Pubitemid 32167632)
81. Moussai D., Mitsui H., Pettersen J. S., Pierson K. C., Shah K. R., Surez-Faras M., Cardinale I. R., Bluth M. J., Krueger J. G., Carucci J. A., The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C Journal of Investigative Dermatology 2011 131 1 229 236
82. Tammela T., He Y., Lyytikk J., Jeltsch M., Markkanen J., Pajusola K., Yl-Herttuala S., Alitalo K., Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins Circulation Research 2007 100 10 1468 1475 (Pubitemid 46834759)
83. Mumprecht V., Detmar M., Lymphangiogenesis and cancer metastasis Journal of Cellular and Molecular Medicine 2009 13 8 1405 1416
84. Gou H. F., Chen X. C., Zhu J., Jiang M., Yang Y., Cao D., Hou M., Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications Journal of Experimental and Clinical Cancer Research 2011 30, article 14 1
85. Han F. H., Li H. M., Zheng D. H., He Y. L., Zhan W. H., The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma European Journal of Surgical Oncology 2010 36 12 1172 1179
86. Deguchi K., Ichikawa D., Soga K., Watanabe K., Kosuga T., Takeshita H., Konishi H., Morimura R., Tsujiura M., Komatsu S., Shiozaki A., Okamoto K., Fujiwara H., Otsuji E., Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancer Anticancer Research 2010 30 6 2361 2366
87. Tanaka T., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Katada T., Shiozaki M., Naganawa Y., Fujii Y., Takeyama H., Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis Journal of Experimental and Clinical Cancer Research 2010 29, article 83 1
88. Kozlowski M., Kowalczuk O., Milewski R., Chyczewski L., Niklinski J., Laudaski J., Serum vascular endothelial growth factors C and D in patients with oesophageal cancer European Journal of Cardio-thoracic Surgery 2010 38 3 260 267
89. Schoppmann S. F., Tamandl D., Roberts L., Jomrich G., Schoppmann A., Zwrtek R., Dubsky P., Gnant M., Jakesz R., Birner P., HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer Annals of Oncology 2010 21 5 955 960
90. Goydos J. S., Gorski D. H., Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma Clinical Cancer Research 2003 9 16 5962 5967 (Pubitemid 38018082)
91. Achen M. G., Jeltsch M., Kukk E., Mkinen T., Vitali A., Wilks A. F., Alitalo K., Stacker S. A., Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proceedings of the National Academy of Sciences of the United States of America 1998 95 2 548 553 (Pubitemid 28083780)
92. Stacker S. A., Stenvers K., Caesar C., Vitali A., Domagala T., Nice E., Roufail S., Simpson R. J., Moritz R., Karpanen T., Alitalo K., Achen M. G., Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers Journal of Biological Chemistry 1999 274 45 32127 32136
93. Baldwin M. E., Roufail S., Halford M. M., Alitalo K., Stacker S. A., Achen M. G., Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis Journal of Biological Chemistry 2001 276 47 44307 44314
94. Cao Y., Linden P., Farnebo J., Cao R., Eriksson A., Kumar V., Qi J. H., Claesson-Welsh L., Alitalo K., Vascular endothelial growth factor C induces angiogenesis in vivo Proceedings of the National Academy of Sciences of the United States of America 1998 95 24 14389 14394 (Pubitemid 28549377)
95. Witzenbichler B., Asahara T., Murohara T., Silver M., Spyridopoulos I., Magner M., Principe N., Kearney M., Hu J. S., Isner J. M., Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia American Journal of Pathology 1998 153 2 381 394 (Pubitemid 28373650)
96. Rutanen J., Rissanen T. T., Markkanen J. E., Gruchala M., Silvennoinen P., Kivel A., Hedman A., Hedman M., Heikura T., Ordén M. R., Stacker S. A., Achen M. G., Hartikainen J., Yl-Herttuala S., Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart Circulation 2004 109 8 1029 1035 (Pubitemid 38282857)
97. Karpanen T., Alitalo K., VEGF-D: a modifier of embryonic lymphangiogenesis Blood 2008 112 5 1547 1548
98. Stacker S. A., Caesar C., Baldwin M. E., Thornton G. E., Williams R. A., Prevo R., Jackson D. G., Nishikawa S. I., Kubo H., Achen M. G., VEGF-D promotes the metastatic spread of tumor cells via the lymphatics Nature Medicine 2001 7 2 186 191 (Pubitemid 32148485)
99. Von Marschall Z., Scholz A., Stacker S. A., Achen M. G., Jackson D. G., Alves F., Schirner M., Haberey M., Thierauch K. H., Wiedenmann B., Rosewicz S., Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer International Journal of Oncology 2005 27 3 669 679
100. Koch M., Dettori D., Van Nuffelen A., Souffreau J., Marconcini L., Wallays G., Moons L., Bruyre F., Oliviero S., Noel A., Foidart J. M., Carmeliet P., Dewerchin M., VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis Journal of Pathology 2009 219 3 356 364
101. Schimanski C. C., Schlaegel F., Jordan M., Moehler M., Sgourakis G., Drescher D. G., Galle P. R., Lang H., Gockel I., VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery World Journal of Surgery 2011 35 5 1010 1016
102. Deng J., Liang H., Sun D., Pan Y., Wang B., Guo Y., Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy Surgery 2009 146 5 896 905
103. Bo C., Xiaopeng D., Chuanliang P., Xiaogang Z., Expression of vascular endothelial growth factors C and D correlates with lymphangiogenesis and lymph node metastasis in lung adenocarcinoma The Thoracic and Cardiovascular Surgeon 2009 57 5 291 294
104. Ferrara N., Gerber H. P., LeCouter J., The biology of VEGF and its receptors Nature Medicine 2003 9 6 669 676 (Pubitemid 36749215)
105. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L. F., Detmar M., VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis Journal of Experimental Medicine 2005 201 7 1089 1099 (Pubitemid 40524677)
106. Bjrndahl M. A., Cao R., Burton J. B., Brakenhielm E., Religa P., Galter D., Wu L., Cao Y., Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis Cancer Research 2005 65 20 9261 9268 (Pubitemid 41507992)
107. Cursiefen C., Chen L., Borges L. P., Jackson D., Cao J., Radziejewski C., D'Amore P. A., Dana M. R., Wiegand S. J., Streilein J. W., VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment Journal of Clinical Investigation 2004 113 7 1040 1050 (Pubitemid 38544126)
108. Rissanen T. T., Markkanen J. E., Gruchala M., Heikura T., Puranen A., Kettunen M. I., Kholov I., Kauppinen R. A., Achen M. G., Stacker S. A., Alitalo K., Yl-Herttuala S., VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses Circulation Research 2003 92 10 1098 1106 (Pubitemid 36665855)
109. Shin J. W., Min M., Larrieu-Lahargue F., Canron X., Kunstfeld R., Nguyen L., Henderson J. E., Bikfalvi A., Detmar M., Hong Y. K., Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis Molecular Biology of the Cell 2006 17 2 576 584 (Pubitemid 43191094)
110. Chang L. K., Garcia-Cardea G., Farnebo F., Fannon M., Chen E. J., Butterfield C., Moses M. A., Mulligan R. C., Folkman J., Kaipainen A., Dose-dependent response of FGF-2 for lymphangiogenesis Proceedings of the National Academy of Sciences of the United States of America 2004 101 32 11658 11663 (Pubitemid 39095352)
111. Kubo H., Cao R., Brkenhielm E., Mkinen T., Cao Y., Alitalo K., Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 8868 8873 (Pubitemid 34693650)
112. Kajiya K., Hirakawa S., Ma B., Drinnenberg I., Detmar M., Hepatocyte growth factor promotes lymphatic vessel formation and function EMBO Journal 2005 24 16 2885 2895 (Pubitemid 43079892)
113. Cao R., Bjrndahl M. A., Gallego M. I., Chen S., Religa P., Hansen A. J., Cao Y., Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action Blood 2006 107 9 3531 3536
114. Li H., Adachi Y., Yamamoto H., Min Y., Ohashi H., Ii M., Arimura Y., Endo T., Lee C. -T., Carbone D. P., Imai K., Shinomura Y., Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45 Cancer 2011 117 14 3135 3147
115. Sawamiphak S., Seidel S., Essmann C. L., Wilkinson G. A., Pitulescu M. E., Acker T., Acker-Palmer A., Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis Nature 2010 465 7297 487 491
116. Augustin H. G., Young Koh G., Thurston G., Alitalo K., Control of vascular morphogenesis and homeostasis through the angiopoietintie system Nature Reviews Molecular Cell Biology 2009 10 3 165 177
117. Helfrich I., Edler L., Sucker A., Thomas M., Christian S., Schadendorf D., Augustin H. G., Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma Clinical Cancer Research 2009 15 4 1384 1392
118. Cao R., Bjrndahl M. A., Religa P., Clasper S., Garvin S., Galter D., Meister B., Ikomi F., Tritsaris K., Dissing S., Ohhashi T., Jackson D. G., Cao Y., PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis Cancer Cell 2004 6 4 333 345 (Pubitemid 39361435)
119. Banziger-Tobler N. E., Halin C., Kajiya K., Detmar M., Growth hormone promotes lymphangiogenesis American Journal of Pathology 2008 173 2 586 597
120. Stoll B. A., Breast cancer: further metabolic-endocrine risk markers? British Journal of Cancer 1997 76 12 1652 1654 (Pubitemid 27520597)
121. Ezzat S., Ezrin C., Yamashita S., Melmed S., Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor Cancer 1993 71 1 66 70 (Pubitemid 23019283)
122. Zudaire E., Martnez A., Cuttitta F., Adrenomedullin and cancer Regulatory Peptides 2003 112 13 175 183 (Pubitemid 36351615)
123. Wlfing P., Diallo R., Kersting C., Wlfing C., Poremba C., Rody A., Greb R. R., Bcker W., Kiesel L., Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up Clinical Cancer Research 2003 9 11 4125 4131 (Pubitemid 37204029)
124. Spinella F., Garrafa E., Castro V. D., Rosan L., Nicotra M. R., Caruso A., Natali P. G., Bagnato A., Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade Cancer Research 2009 69 6 2669 2676
125. Clasper S., Royston D., Baban D., Cao Y., Ewers S., Butz S., Vestweber D., Jackson D. G., A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis Cancer Research 2008 68 18 7293 7303
126. Larrieu-Lahargue F., Welm A. L., Thomas K. R., Li D. Y., Netrin-4 induces lymphangiogenesis in vivo Blood 2010 115 26 5418 5426
127. Garmy-Susini B., Makale M., Fuster M., Varner J. A., Methods to study lymphatic vessel integrins Methods in Enzymology 2007 426 415 438
128. Padera T. P., Kadambi A., Di Tomaso E., Mouta Carreira C., Brown E. B., Boucher Y., Choi N. C., Mathisen D., Wain J., Mark E. J., Munn L. L., Jain R. K., Lymphatic metastasis in the absence of functional intratumor lymphatics Science 2002 296 5574 1883 1886 (Pubitemid 34596277)
129. Tobler N. E., Detmar M., Tumor and lymph node lymphangiogenesisimpact on cancer metastasis Journal of Leukocyte Biology 2006 80 4 691 696 (Pubitemid 44835883)
130. Wang X. L., Fang J. P., Tang R. Y., Chen X. M., Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases BMC Cancer 2010 10, article 299
131. Skobe M., Hamberg L. M., Hawighorst T., Schirner M., Wolf G. L., Alitalo K., Detmar M., Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma American Journal of Pathology 2001 159 3 893 903 (Pubitemid 32847180)
132. Higashiyama A., Watanabe H., Okumura K., Yagita H., Involvement of tumor necrosis factor and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis Cancer Immunology Immunotherapy 1996 42 4 231 236 (Pubitemid 26183206)
133. Rice G. E., Bevilacqua M. P., An inducible endothelial cell surface glycoprotein mediates melanoma adhesion Science 1989 246 4935 1303 1306 (Pubitemid 20066715)
134. Langley R. R., Carlisle R., Ma L., Specian R. D., Gerritsen M. E., Granger D. N., Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma Microcirculation 2001 8 5 335 345 (Pubitemid 33598137)
135. De la Monte S. M., Moore G. W., Hutchins G. M., Patterned distribution of metastases from malignant melanoma in humans Cancer Research 1983 43 7 3427 3433 (Pubitemid 13061609)
136. Bromley S. K., Thomas S. Y., Luster A. D., Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics Nature Immunology 2005 6 9 895 901 (Pubitemid 43090444)
137. Debes G. F., Arnold C. N., Young A. J., Krautwald S., Lipp M., Hay J. B., Butcher E. C., Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues Nature Immunology 2005 6 9 889 894 (Pubitemid 43090443)
138. Darash-Yahana M., Pikarsky E., Abramovitch R., Zeira E., Pal B., Karplus R., Belder K., Avniel S., Kasem S., Galun E., Peled A., Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis FASEB Journal 2004 18 11 1240 1242 (Pubitemid 39561563)
139. Arya M., Patel H. R. H., McGurk C., Tatoud R., Klocker H., Masters J., Williamson M., The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis Journal of Experimental Therapeutics and Oncology 2004 4 4 291 303 (Pubitemid 40189442)
140. Mller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E., McClanahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verstegui E., Zlotnik A., Involvement of chemokine receptors in breast cancer metastasis Nature 2001 410 6824 50 56 (Pubitemid 32225831)
141. Wiley H. E., Gonzalez E. B., Maki W., Wu M. T., Hwang S. T., Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma Journal of the National Cancer Institute 2001 93 21 1638 1643 (Pubitemid 33094871)
142. Shields J. D., Emmett M. S., Dunn D. B. A., Joory K. D., Sage L. M., Rigby H., Mortimer P. S., Orlando A., Levick J. R., Bates D. O., Chemokine-mediated migration of melanoma cells towards lymphaticsa mechanism contributing to metastasis Oncogene 2007 26 21 2997 3005 (Pubitemid 46733648)
143. Orimo A., Gupta P. B., Sgroi D. C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V. J., Richardson A. L., Weinberg R. A., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 2005 121 3 335 348 (Pubitemid 40692295)
144. Singh S., Singh U. P., Grizzle W. E., Lillard J. W. Jr., CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion Laboratory Investigation 2004 84 12 1666 1676 (Pubitemid 39600573)
145. Doeden K., Ma Z., Narasimhan B., Swetter S. M., Detmar M., Dadras S. S., Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis Journal of Cutaneous Pathology 2009 36 7 772 780
146. Hyung W. J., Lee J. H., Choi S. H., Min J. S., Noh S. H., Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer Annals of Surgical Oncology 2002 9 6 562 567 (Pubitemid 34774417)
147. Lee A. H. S., Pinder S. E., Macmillan R. D., Mitchell M., Ellis I. O., Elston C. W., Blamey R. W., Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma European Journal of Cancer 2006 42 3 357 362 (Pubitemid 43132891)
148. Dicken B. J., Graham K., Hamilton S. M., Andrews S., Lai R., Listgarten J., Jhangri G. S., Saunders L. D., Damaraju S., Cass C., Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques Annals of Surgery 2006 243 1 64 73 (Pubitemid 43054056)
149. Schoppmann S. F., Bayer G., Aumayr K., Taucher S., Geleff S., Rudas M., Kubista E., Hausmaninger H., Samonigg H., Gnant M., Jakesz R., Horvat R., Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer Annals of Surgery 2004 240 2 306 312 (Pubitemid 38963023)
150. Das S., Ladell D. S., Podgrabinska S., Ponomarev V., Nagi C., Fallon J. T., Skobe M., Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases Cancer Research 2010 70 5 1814 1824
151. Hirakawa S., Brown L. F., Kodama S., Paavonen K., Alitalo K., Detmar M., VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites Blood 2007 109 3 1010 1017 (Pubitemid 46220646)
152. Ishii H., Chikamatsu K., Sakakura K., Miyata M., Furuya N., Masuyama K., Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma Oral Oncology 2010 46 5 373 378
153. Harrell M. I., Iritani B. M., Ruddell A., Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis American Journal of Pathology 2007 170 2 774 786 (Pubitemid 47339411)
154. Dadras S. S., Lange-Asschenfeldt B., Velasco P., Nguyen L., Vora A., Muzikansky A., Jahnke K., Hauschild A., Hirakawa S., Mihm M. C., Detmar M., Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes Modern Pathology 2005 18 9 1232 1242 (Pubitemid 43079923)
155. Van Den Eynden G. G., Vandenberghe M. K., Van Dam P. J. H., Colpaert C. G., Van Dam P., Dirix L. Y., Vermeulen P. B., Van Marck E. A., Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node Clinical Cancer Research 2007 13 18 5391 5397 (Pubitemid 47510365)
156. He Y., Rajantie I., Ilmonen M., Makinen T., Karkkainen M. J., Haiko P., Salven P., Alitalo K., Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis Cancer Research 2004 64 11 3737 3740 (Pubitemid 38697279)
157. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., Harding T., Jooss K., Takahashi T., Alitalo K., Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels Cancer Research 2005 65 11 4739 4746 (Pubitemid 40740810)
158. De Palma M., Venneri M. A., Galli R., Sergi L. S., Politi L. S., Sampaolesi M., Naldini L., Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors Cancer Cell 2005 8 3 211 226 (Pubitemid 41317592)
159. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N. R., Crystal R. G., Moore M. A. S., Hajjar K. A., Manova K., Benezra R., Rafii S., Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nature Medicine 2001 7 11 1194 1201 (Pubitemid 33063774)
160. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Yung S., Chimenti S., Landsman L., Abramovitch R., Keshet E., VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells Cell 2006 124 1 175 189 (Pubitemid 43069318)
161. Gao D., Nolan D. J., Mellick A. S., Bambino K., McDonnell K., Mittal V., Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis Science 2008 319 5860 195 198
162. Religa P., Cao R., Bjorndahl M., Zhou Z., Zhu Z., Cao Y., Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels Blood 2005 106 13 4184 4190 (Pubitemid 41775925)
163. Maruyama K., Ii M., Cursiefen C., Jackson D. G., Keino H., Tomita M., Van Rooijen N., Takenaka H., D'Amore P. A., Stein-Streilein J., Losordo D. W., Streilein J. W., Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages Journal of Clinical Investigation 2005 115 9 2363 2372 (Pubitemid 41266198)
164. Kerjaschki D., Huttary N., Raab I., Regele H., Bojarski-Nagy K., Bartel G., Krber S. M., Greinix H., Rosenmaier A., Karlhofer F., Wick N., Mazal P. R., Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants Nature Medicine 2006 12 2 230 234 (Pubitemid 43214751)
165. Hamrah P., Chen L., Zhang Q., Dana M. R., Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells American Journal of Pathology 2003 163 1 57 68 (Pubitemid 36759591)
166. Zumsteg A., Baeriswyl V., Imaizumi N., Schwendener R., Regg C., Christofori G., Myeloid cells contribute to tumor lymphangiogenesis PLoS One 2009 4 9
167. Bagley R. G., Weber W., Rouleau C., Yao M., Honma N., Kataoka S., Ishida I., Roberts B. L., Teicher B. A., Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers International Journal of Oncology 2009 34 3 619 627
168. Roobrouck V. D., Clavel C., Jacobs S. A., Ulloa-Montoya F., Crippa S., Sohni A., Roberts S. J., Luyten F. P., Van Gool S. W., Sampaolesi M., Delforge M., Luttun A., Verfaillie C. M., Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions Stem Cells 2011 29 5 871 882
169. Karnoub A. E., Dash A. B., Vo A. P., Sullivan A., Brooks M. W., Bell G. W., Richardson A. L., Polyak K., Tubo R., Weinberg R. A., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 2007 449 7162 557 563 (Pubitemid 47525152)
170. Medici D., Shore E. M., Lounev V. Y., Kaplan F. S., Kalluri R., Olsen B. R., Conversion of vascular endothelial cells into multipotent stem-like cells Nature Medicine 2010 16 12 1400 1406
171. Achen M. G., Mann G. B., Stacker S. A., Targeting lymphangiogenesis to prevent tumour metastasis British Journal of Cancer 2006 94 10 1355 1360 (Pubitemid 43772266)
172. Young N., Hahn C. N., Poh A., Dong C., Wilhelm D., Olsson J., Muscat G. E. O., Parsons P., Gamble J. R., Koopman P., Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development Journal of the National Cancer Institute 2006 98 15 1060 1067 (Pubitemid 44288154)
173. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., Alitalo K., Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing American Journal of Pathology 2000 156 5 1499 1504 (Pubitemid 30646689)
174. Partanen T. A., Alitalo K., Miettinen M., Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors Cancer 1999 86 11 2406 2412 (Pubitemid 30010384)
175. Valtola R., Salven P., Heikkil P., Taipale J., Joensuu H., Rehn M., Pihlajaniemi T., Weich H., DeWaal R., Alitalo K., VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer American Journal of Pathology 1999 154 5 1381 1390 (Pubitemid 29226433)
176. Hong Y. K., Foreman K., Shin J. W., Hirakawa S., Curry C. L., Sage D. R., Libermann T., Dezube B. J., Fingeroth J. D., Detmar M., Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus Nature Genetics 2004 36 7 683 685 (Pubitemid 38886627)
177. Dadras S. S., Skrzypek A., Nguyen L., Shin J. W., Schulz M. M. P., Arbiser J., Mihm M. C., Detmar M., Prox-1 promotes invasion of kaposiform hemangioendotheliomas Journal of Investigative Dermatology 2008 128 12 2798 2806
178. Hosking B. M., Wang S. C. M., Downes M., Koopman P., Muscat G. E. O., The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the sry-related high mobility group box gene, Sox18 Journal of Biological Chemistry 2004 279 7 5314 5322 (Pubitemid 38220552)
179. Fontijn R. D., Volger O. L., Fledderus J. O., Reijerkerk A., De Vries H. E., Horrevoets A. J. G., SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function American Journal of Physiology 2008 294 2 H891 H900 (Pubitemid 351253301)
180. Qin J., Chen X., Xie X., Tsai M. J., Tsai S. Y., COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis Proceedings of the National Academy of Sciences of the United States of America 2010 107 8 3687 3692
181. Hayashi H., Kume T., Foxc2 transcription factor as a regulator of angiogenesis via induction of integrin 3 expression Cell Adhesion and Migration 2009 3 1 24 26
182. Nishida N., Mimori K., Yokobori T., Sudo T., Tanaka F., Shibata K., Ishii H., Doki Y., Mori M., FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma Annals of Surgical Oncology 2011 18 2 535 542
183. Pez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Vials F., Inoue M., Bergers G., Hanahan D., Casanovas O., Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 2009 15 3 220 231
184. Faivre S., Demetri G., Sargent W., Raymond E., Molecular basis for sunitinib efficacy and future clinical development Nature Reviews Drug Discovery 2007 6 9 734 745 (Pubitemid 47338181)
185. Roskoski R. Jr., Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor Biochemical and Biophysical Research Communications 2007 356 2 323 328 (Pubitemid 46452568)
186. Fischer I., Cunliffe C. H., Bollo R. J., Raza S., Monoky D., Chiriboga L., Parker E. C., Golfinos J. G., Kelly P. J., Knopp E. A., Gruber M. L., Zagzag D., Narayana A., High-grade glioma before and after treatment with radiation and Avastin: initial observations Neuro-Oncology 2008 10 5 700 708
187. Narayana A., Kelly P., Golfinos J., Parker E., Johnson G., Knopp E., Zagzag D., Fischer I., Raza S., Medabalmi P., Eagan P., Gruber M. L., Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival Journal of Neurosurgery 2009 110 1 173 180
188. Norden A. D., Young G. S., Setayesh K., Muzikansky A., Klufas R., Ross G. L., Ciampa A. S., Ebbeling L. G., Levy B., Drappatz J., Kesari S., Wen P. Y., Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence Neurology 2008 70 10 779 787
189. Caunt M., Mak J., Liang W. C., Stawicki S., Pan Q., Tong R. K., Kowalski J., Ho C., Reslan H. B., Ross J., Berry L., Kasman I., Zlot C., Cheng Z., LeCouter J., Filvaroff E. H., Plowman G., Peale F., French D., Carano R., Koch A., Wu Y., Watts R. J., Tessier-Lavigne M., Bagri A., Blocking neuropilin-2 function inhibits tumor cell metastasis Cancer Cell 2008 13 4 331 342 (Pubitemid 351446192)
190. Sleeman J., Schmid A., Thiele W., Tumor lymphatics Seminars in Cancer Biology 2009 19 5 285 297
191. Wissmann C., Detmar M., Pathways targeting tumor lymphangiogenesis Clinical Cancer Research 2006 12 23 6865 6868 (Pubitemid 44974477)
192. Lin J., Lalani A. S., Harding T. C., Gonzalez M., Wu W. W., Luan B., Tu G. H., Koprivnikar K., VanRoey M. J., He Y., Alitalo K., Jooss K., Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor Cancer Research 2005 65 15 6901 6909 (Pubitemid 41060729)
193. Chen Z., Varney M. L., Backora M. W., Cowan K., Solheim J. C., Talmadge J. E., Singh R. K., Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival Cancer Research 2005 65 19 9004 9011 (Pubitemid 41377392)
194. Rinderknecht M., Villa A., Ballmer-Hofer K., Neri D., Detmar M., Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-c block its interaction with vegf receptor-2 and 3 PLoS One 2010 5 8
195. Zhang D., Li B., Shi J., Zhao L., Zhang X., Wang C., Hou S., Qian W., Kou G., Wang H., Guo Y., Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein Cancer Research 2010 70 6 2495 2503
196. Pytowski B., Goldman J., Persaud K., Wu Y., Witte L., Hicklin D. J., Skobe M., Boardman K. C., Swartz M. A., Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody Journal of the National Cancer Institute 2005 97 1 14 21
197. Roberts N., Kloos B., Cassella M., Podgrabinska S., Persaud K., Wu Y., Pytowski B., Skobe M., Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2 Cancer Research 2006 66 5 2650 2657
198. He Y., Kozaki K. I., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., Alitalo K., Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling Journal of the National Cancer Institute 2002 94 11 819 825 (Pubitemid 34705053)
199. Krishnan J., Kirkin V., Steffen A., Hegen M., Weih D., Tomarev S., Wilting J., Sleeman J. P., Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats Cancer Research 2003 63 3 713 722 (Pubitemid 36158152)
200. Wong S. Y., Haack H., Crowley D., Barry M., Bronson R. T., Hynes R. O., Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis Cancer Research 2005 65 21 9789 9798 (Pubitemid 41541456)
201. Yashiro M., Shinto O., Nakamura K., Tendo M., Matsuoka T., Matsuzaki T., Kaizaki R., Ohira M., Miwa A., Hirakawa K., Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model British Journal of Cancer 2009 101 7 1100 1106
202. Liu H., Yang Y., Xiao J., Lv Y., Liu Y., Yang H., Zhao L., Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C Anatomical Record 2009 292 10 1577 1583
203. Garmy-Susini B., Avraamides C. J., Schmid M. C., Foubert P., Ellies L. G., Barnes L., Feral C., Papayannopoulou T., Lowy A., Blair S. L., Cheresh D., Ginsberg M., Varner J. A., Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis Cancer Research 2010 70 8 3042 3051
204. Achen M. G., Roufail S., Domagala T., Catimel B., Nice E. C., Geleick D. M., Murphy R., Scott A. M., Caesar C., Makinen T., Alitalo K., Stacker S. A., Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3 European Journal of Biochemistry 2000 267 9 2505 2515 (Pubitemid 30304244)
205. Stacker S. A., Achen M. G., Jussila L., Baldwin M. E., Alitalo K., Lymphangiogenesis and cancer metastasis Nature Reviews Cancer 2002 2 8 573 583 (Pubitemid 37328924)
206. Achen M. G., McColl B. K., Stacker S. A., Focus on lymphangiogenesis in tumor metastasis Cancer Cell 2005 7 2 121 127 (Pubitemid 40248338)
207. Burton J. B., Priceman S. J., Sung J. L., Brakenhielm E., Dong S. A., Pytowski B., Alitalo K., Wu L., Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis Cancer Research 2008 68 19 7828 7837
208. Xu Y., Yuan L., Mak J., Pardanaud L., Caunt M., Kasman I., Larrivée B., Del Toro R., Suchting S., Medvinsky A., Silva J., Yang J., Thomas J. L., Koch A. W., Alitalo K., Eichmann A., Bagri A., Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3 Journal of Cell Biology 2010 188 1 115 130
209. Basak A., Khatib A. M., Mohottalage D., Basak S., Kolajova M., Bag S. S., Basak A., A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C PloS One 2009 4 11
210. Lin B., Podar K., Gupta D., Tai Y. T., Li S., Weller E., Hideshima T., Lentzsch S., Davies F., Li C., Weisberg E., Schlossman R. L., Richardson P. G., Griffin J. D., Wood J., Munshi N. C., Anderson K. C., The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironment Cancer Research 2002 62 17 5019 5026 (Pubitemid 34984429)
211. Yau T., Chan P., Pang R., Ng K., Fan S. T., Poon R. T., Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma Cancer 2010 116 21 5022 5029
212. Ruggeri B., Singh J., Gingrich D., Angeles T., Albom M., Chang H., Robinson C., Hunter K., Dobrzanski P., Jones-Bolin S., Aimone L., Klein-Szanto A., Herbert J. M., Bono F., Schaeffer P., Casellas P., Bourie B., Pili R., Isaacs J., Ator M., Hudkins R., Vaught J., Mallamo J., Dionne C., CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models Cancer Research 2003 63 18 5978 5991 (Pubitemid 37187500)
213. Wilhelm S. M., Carter C., Tang L., Wilkie D., McNabola A., Rong H., Chen C., Zhang X., Vincent P., McHugh M., Cao Y., Shujath J., Gawlak S., Eveleigh D., Rowley B., Liu L., Adnane L., Lynch M., Auclair D., Taylor I., Gedrich R., Voznesensky A., Riedl B., Post L. E., Bollag G., Trail P. A., BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis Cancer Research 2004 64 19 7099 7109 (Pubitemid 39331023)
214. Konings I. R. H. M., De Jonge M. J. A., Burger H., Van Der Gaast A., Van Beijsterveldt L. E. C., Winkler H., Verweij J., Yuan Z., Hellemans P., Eskens F. A. L. M., Phase i and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours British Journal of Cancer 2010 103 7 987 992
215. De Jonge M. J. A., Dumez H., Kitzen J. J.E. M., Beuselinck B., Verweij J., Courtney R., Battista A., Brega N., Schffski P., Phase i safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours European Journal of Cancer 2011 47 9 1328 1335
216. de Castro Junior G., Puglisi F., de Azambuja E., El Saghir N. S., Awada A., Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the "do ut des" paradigm) Critical Reviews in Oncology/Hematology 2006 59 1 40 50 (Pubitemid 43903280)
217. Saharinen P., Tammela T., Karkkainen M. J., Alitalo K., Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation Trends in Immunology 2004 25 7 387 395 (Pubitemid 38780956)
218. Schomber T., Zumsteg A., Strittmatter K., Crnic I., Antoniadis H., Littlewood-Evans A., Wood J., Christofori G., Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis Molecular Cancer Therapeutics 2009 8 1 55 63
219. Nyberg P., Xie L., Kalluri R., Endogenous inhibitors of angiogenesis Cancer Research 2005 65 10 3967 3979 (Pubitemid 40775631)
220. Heishi T., Hosaka T., Suzuki Y., Miyashita H., Oike Y., Takahashi T., Nakamura T., Arioka S., Mitsuda Y., Takakura T., Hojo K., Matsumoto M., Yamauchi C., Ohta H., Sonoda H., Sato Y., Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis American Journal of Pathology 2010 176 4 1950 1958
221. Downes M., Franois M., Ferguson C., Parton R. G., Koopman P., Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation Human Molecular Genetics 2009 18 15 2839 2850
222. Matsui T., Kanai-Azuma M., Hara K., Matoba S., Hiramatsu R., Kawakami H., Kurohmaru M., Koopman P., Kanai Y., Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice Journal of Cell Science 2006 119 17 3513 3526 (Pubitemid 44501857)
223. Seo S., Fujita H., Nakano A., Kang M., Duarte A., Kume T., The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development Developmental Biology 2006 294 2 458 470 (Pubitemid 43884821)
224. Mani S. A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., Kutok J. L., Hartwell K., Richardson A. L., Weinberg R. A., Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers Proceedings of the National Academy of Sciences of the United States of America 2007 104 24 10069 10074 (Pubitemid 47175264)
225. Sano H., LeBoeuf J. P., Novitskiy S. V., Seo S., Zaja-Milatovic S., Dikov M. M., Kume T., The Foxc2 transcription factor regulates tumor angiogenesis Biochemical and Biophysical Research Communications 2010 392 2 201 206
226. Zurita A. J., George D. J., Shore N. D., Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial. Annals of Oncology. In press
227. Tammela T., Saaristo A., Holopainen T., Yl-Herttuala S., Andersson L. C., Virolainen S., Immonen I., Alitalo K., Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis Science Translational Medicine 2011 3 69 69ra11
228. Thiele W., Sleeman J. P., Tumor-induced lymphangiogenesis: a target for cancer therapy? Journal of Biotechnology 2006 124 1 224 241 (Pubitemid 43816134)
229. Clark B., Sitzia J., Harlow W., Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study Monthly Journal of the Association of Physicians 2005 98 5 343 348 (Pubitemid 40663122)
230. Warren A. G., Brorson H., Borud L. J., Slavin S. A., Lymphedema: a comprehensive review Annals of Plastic Surgery 2007 59 4 464 472 (Pubitemid 47494139)
231. Tammela T., Saaristo A., Holopainen T., Lyytikk J., Kotronen A., Pitkonen M., Abo-Ramadan U., Yl-Herttuala S., Petrova T. V., Alitalo K., Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation Nature Medicine 2007 13 12 1458 1466 (Pubitemid 350224251)